The Drug Pricing Lab

A nonpartisan research and policy center at the Memorial Sloan Kettering Cancer Center.

Drug Pricing Lab Tracker [1]

The DPL Policy Tracker keeps tabs on federal policy proposals to address US drug pricing issues.

About the Drug Pricing Lab

Dr. Bach’s Drug Pricing Lab (DPL) is based at Memorial Sloan Kettering Cancer Center. The DPL focuses on the development of rational approaches to drug pricing and health insurance coverage that sustain innovation while ensuring patient access and affordability. The DPL focuses its efforts on four major work streams:

1. Research on the current state of U.S. drug pricing and its effects
2. Development of solutions to align drug prices with value
3. Pilot programs to test solutions in real world settings
4. Evidence-based and unbiased resources for policy makers

The DPL conducts non-partisan, independent academic research, which is made publicly available. All views expressed are our own, and do not represent the views of Memorial Sloan Kettering Cancer Center. The DPL receives funding from the Laura and John Arnold Foundation and Kaiser Permanente.

References:

1. Drug Pricing Lab at Memorial Sloan Kettering